207 related articles for article (PubMed ID: 18279216)
1. Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma.
Miyahara H; Korematsu S; Nagakura T; Izumi T
Pediatr Int; 2008 Feb; 50(1):103-8. PubMed ID: 18279216
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
You-Ning L; Humphries M; Du X; Wang L; Jiang J
Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
[TBL] [Abstract][Full Text] [Related]
7. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK
Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration.
Whelan GJ; Blumer JL; Martin RJ; Szefler SJ;
J Allergy Clin Immunol; 2005 Sep; 116(3):525-30. PubMed ID: 16159619
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
[TBL] [Abstract][Full Text] [Related]
11. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
Zhang QL; Zheng JP; Pan WH; He H; Chen GL; An JY; Yuan LF; Luo DF
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
[TBL] [Abstract][Full Text] [Related]
12. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC; Martin P; Mezzanotte WS
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
Harnest U; Price D; Howes T; Sussman G
J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
[TBL] [Abstract][Full Text] [Related]
14. A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.
Kupczyk M; Majak P; Kuna P; Asankowicz-Bargiel B; Barańska E; Dobek R; Garbicz S; Jerzyńska J; Latos A; Machowiak W; Majorek-Olechowska B; Olech-Cudzik A; Poziomkowska-Gęsicka I; Rulewicz-Warniełło M; Świderska A; Tarnowski M; Kopyto P
Respir Med; 2021 Jan; 176():106274. PubMed ID: 33276251
[TBL] [Abstract][Full Text] [Related]
15. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
Mehta R; Moore A; Riddell K; Joshi S; Chan R
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
[TBL] [Abstract][Full Text] [Related]
17. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
Gillespie M; Song S; Steinfeld J
Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
[TBL] [Abstract][Full Text] [Related]
19. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ; Martin RJ; King TS; Boushey HA; Cherniack RM; Chinchilli VM; Craig TJ; Dolovich M; Drazen JM; Fagan JK; Fahy JV; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lazarus SC; Lemanske RF; Mauger E; Peters SP; Sorkness CA;
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
Hojo M; Shirai T; Hirashima J; Iikura M; Sugiyama H
Pulm Pharmacol Ther; 2016 Apr; 37():43-8. PubMed ID: 26898348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]